Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "Markets"

1430 News Found

Dabur profit jumps 16% as FMCG growth gains pace
News | May 08, 2026

Dabur profit jumps 16% as FMCG growth gains pace

Hair care & quick commerce shine


Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
Drug Approval | May 07, 2026

Venus Remedies gets marketing authorization for Ceftriaxone in Argentina

Approval strengthens the company’s growing international anti-infective portfolio


Emcure crosses US$1 billion revenue milestone in FY26; PAT rises 33%
Biopharma | May 06, 2026

Emcure crosses US$1 billion revenue milestone in FY26; PAT rises 33%

Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth


Govt, academia and industry collaboration crucial for scientific progress: Dr Jitendra Singh
Policy | May 05, 2026

Govt, academia and industry collaboration crucial for scientific progress: Dr Jitendra Singh

The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders


Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025
Biopharma | May 05, 2026

Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025

The private funding rose 38% amid growing international collaborations and CDMO demand


OneSource powers second generic semaglutide nod in Canada
Drug Approval | May 05, 2026

OneSource powers second generic semaglutide nod in Canada

Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs


KPMG report finds healthcare CEOs betting big on AI amid workforce and system pressures
Healthcare | May 05, 2026

KPMG report finds healthcare CEOs betting big on AI amid workforce and system pressures

Report highlights growing confidence in digitalisation and AI, even as healthcare leaders remain concerned about workforce gaps, cybersecurity, and data readiness


NIFTY Pharma remains resilient amid mixed market sentiment
News | May 05, 2026

NIFTY Pharma remains resilient amid mixed market sentiment

Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures


Moderna posts Q1 2026 loss despite revenue surge
News | May 04, 2026

Moderna posts Q1 2026 loss despite revenue surge

Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets


Axithra appoints Lars Kongsbak as CEO ahead of clinical validation and Series A fundraise
People | May 04, 2026

Axithra appoints Lars Kongsbak as CEO ahead of clinical validation and Series A fundraise

Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions